Spencer Kahn

Spencer Kahn supports the Centers for Disease Control and Prevention’s Office of Acquisition Services in executing mission-critical procurements that enable public health infrastructure, laboratory diagnostics, and scientific research capabilities. He manages a diverse portfolio of acquisitions focused on high-complexity scientific equipment, analytical instrumentation, and technical consulting services essential for infectious disease surveillance and biomedical research. His work ensures the CDC can rapidly deploy cutting-edge tools for pathogen detection, data analysis, and laboratory modernization, aligning procurement strategy with national health security priorities. Kahn maintains established relationships with leading contractors including General Dynamics Information Technology, GlaxoSmithKline, MRIGLOBAL, and Cepheid, reflecting a preference for vendors with proven expertise in clinical diagnostics, laboratory automation, and public health response systems. His contracting patterns emphasize long-term partnerships with organizations capable of delivering specialized, regulated products and services under strict federal compliance standards, often involving complex technical specifications and validation requirements. While the majority of his acquisitions are competed without set-asides—reflecting the technical specificity and scale of required capabilities—Kahn consistently prioritizes small business participation, with nearly 30% of awards designated as total small business set-asides under FAR 19.5. This demonstrates a deliberate effort to integrate capable small firms into the CDC’s scientific supply chain, particularly those with niche expertise in laboratory services and technical consulting. His procurement focus is concentrated in NAICS 334516 (analytical laboratory instrument manufacturing) and 541990 (other professional, scientific, and technical services), underscoring deep engagement with high-precision diagnostic equipment, biosafety infrastructure, and expert advisory services supporting epidemiological operations. Kahn’s expertise lies at the intersection of public health science and federal acquisition, ensuring that procurement decisions directly enhance the nation’s capacity to detect, respond to, and mitigate emerging health threats.